Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Has announcements
×
Breast Neoplasms
×
olaparib
×
Clear all
Filters
3
NCT02032823
2026-02-17
OlympiA
AstraZeneca
Phase 3
Active not recruiting
1,836 enrolled
20 charts
1 FDA
NCT02000622
2026-02-13
OlympiAD
AstraZeneca
Phase 3
Completed
302 enrolled
26 charts
1 FDA